The Anambra State Commissioner for Health, Dr Vincent Okpala has said that the continued partnership with the European Union (EU) and World Health Organisation (WHO), has improved the healthcare sector of the state through a health system strengthening support.
The commissioner, stated this while declaring open, a one-day technical workgroup meeting in Awka, on Tuesday, which had in attendance, members of House Committee on Health, representatives from the Ministries, Departments, Agencies, and the Academia.
ALSO READ: UK borrows hit record high £128bn in 3 months to June
Dr Okpala emphasised the importance of finance in the health sector and its relevance in achieving goals and objectives, urging participants to bring in good ideas and suggestions that would help the sector.
He commended the EU/WHO support in strengthening the health system and creating objectives of achieving universal health coverage in the state.
The Special Adviser to the Governor on Health, Dr Simeon Onyemaechi, who rolled out Anambra State Mobile Health Insurance System, on his part, said that people could be adopted from any part of the world into the scheme with any currency which will be followed by the reception of corresponding code on the platform after enrollment.
YOU SHOULD NOT MISS THESE HEADLINES FROM NIGERIAN TRIBUNE
N1.32bn, not N1.5bn, was spent on COVID-19 palliatives, Pondei explains
THE ongoing investigative hearing into the allegations bordering on misappropriation of N81.5 billion by the management of Niger Delta Development Commission (NDDC) was temporarily halted on Monday after the acting managing director of the commission, Professor Daniel Pondei fainted and was… Read Full Story
COVID-19: Nigeria Records 562 New Cases, Total Now 37,225
The Nigeria Centre for Disease Control (NCDC) has confirmed 562 new cases of COVID-19 in the country, with national toll now put at 37,225… Read Full Story
UK Secures Early Access To 90 Million Doses Of COVID-19 Vaccines
The UK Government has entered partnerships with BioNtech/Pfizer and Valneva who are developing vaccines to protect against COVID-19. It has also secured early access to treatments containing COVID-19 neutralising antibodies from AstraZeneca, in order to treat those unable to receive vaccines, such as the… Read Full Story
and then